FDA Adverse Event Injury Summary report: N

TANDEM T:SLIM INSULIN DELIVERY SYSTEM

MDR report key: 6049022 · Received October 21, 2016

Report

Report Number
3007981285-2016-15457
Event Type
Injury
Date Received
October 21, 2016
Date of Event
September 4, 2016
Report Date
October 2, 2016
Manufacturer
TANDEM DIABETES CARE
Product Code
LZG
PMA / PMN Number
K111210
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE T:SLIM CARTRIDGE USER GUIDE INDICATES THAT HUMALOG HAS BEEN TESTED UP TO 48 HOURS. REPLACE THE CARTRIDGE EVERY 48 HOURS IF USING HUMALOG. NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. DEVICE NOT RETURNED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CUSTOMER HAS EXPERIENCED ELEVATED BLOOD GLUCOSE (BG) LEVELS RANGE FROM (230-286 MG/DL) FOR THE PAST MONTH. THE CUSTOMER WOULD BOLUS TO STABILIZE BG LEVEL. DURING TROUBLESHOOTING WITH TANDEM TECHNICAL SUPPORT (CTS), A SYSTEM CHECK WAS PERFORMED AND INDICATED THAT THE PUMP WAS FUNCTIONING AS INTENDED. THE CUSTOMER STATED TO USE HUMALOG INSULIN IN THE CARTRIDGE FOR 3-3.5 DAYS. THE CUSTOMER WAS EDUCATED PER HUMALOG LABELING IT IS ONLY TESTED FOR UP TO 48 HOURS. A RECOMMENDATION WAS MADE FOR THE CUSTOMER TO CONTACT THE HEALTHCARE PROVIDER TO DISCUSS FACTORS THAT MAY AFFECT BG LEVEL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
700163 TANDEM T:SLIM INSULIN DELIVERY SYSTEM INSULIN PUMP LZG TANDEM DIABETES CARE 004628

Patients

Seq Age Sex Outcome Treatment
1 42 YR Other INFUSION SET: INSET, INSULIN: HUMALOG